Disclaimer:
This website is intended to assist with patient education and should not be used as a diagnostic, treatment or prescription service, forum or platform. Always consult your own healthcare practitioner for a more personalised and detailed opinion
To screen for, detect, and monitor treatment for congenital adrenal hyperplasia (CAH); sometimes to help rule out other conditions with similar symptoms
As part of a routine newborn screen; when an infant's sex is not obvious (ambiguous genitalia); when a young female has increased growth of facial and body hair (hirsutism) or other symptoms that could be related to elevated male sex hormones (virilization); when a male child has premature sexual development; periodically to monitor CAH treatment
A blood sample drawn from a vein in your arm or blood from a heelstick for an infant
None, but an early morning collection may be requested; it may also be requested that the blood sample be collected at a specific time during a woman's menstrual cycle.
17-hydroxyprogesterone (17-OHP) is a steroid hormone, derived from cholesterol, and is produced as part of the process of making the hormone cortisol. This test measures the amount of 17-OHP in the blood to detect and/or evaluate congenital adrenal hyperplasia (CAH), an inherited condition that results in decreased adrenal cortisol and aldosterone and increased male sex hormone (androgen) production.
Cortisol is produced by the adrenal glands. It helps break down protein, glucose, and lipids, maintains blood pressure, and regulates the immune system. The adrenal glands also produce other steroid hormones such as aldosterone, which helps regulate salt levels and blood pressure, and androgens, substances that, like testosterone, cause male sexual features as well as other effects.
Several enzymes are required to complete the steps involved in the production of cortisol. If one or more of these enzymes is deficient or dysfunctional, then inadequate amounts of cortisol are produced, as occurs with CAH. The most common cause of CAH is a lack of the enzyme 21-hydroxylase, accounting for about 90% of cases.
Because a low level of cortisol causes an elevation in the level of a particular pituitary hormone that stimulates adrenal growth and hormone production (adrenocorticotropic hormone, or ACTH), the adrenal gland increases in size (adrenal hyperplasia). However, the increased size and activity cannot overcome the block in cortisol production. Other substances such as 17-hydroxyprogesterone and androgens that do not need the defective enzyme are produced in excess. This is why testing for 17-OHP can help to detect CAH.
CAH with 21-hydroxylase deficiency is inherited as either a severe or mild type:
Due to the excess androgens, the development of male sexual characteristics in females (virilization) can occur. Female babies may have sex organs that are not clearly male or female (ambiguous genitalia), making it difficult to initially determine their sex. Females may have excess hair growth on face and body (hirsutism) and other male secondary sexual characteristics during childhood and adolescence as well as irregular menstruation. Males with this condition will appear normal at birth but may start to develop sexual characteristics prematurely.
A blood sample is obtained by inserting a needle into a vein in the arm or by pricking the heel of an infant.
No test preparation is needed, but an early morning collection may be requested. It may also be requested that the blood sample be collected at a specific time during a woman's menstrual cycle.